James A Schoeneck insider trades

Open-market stock purchases and sales by James A Schoeneck, Director at Calidi Biotherapeutics, Inc, from SEC Form 4 filings since Dec 9, 2010.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +12%.

Recent trades

DateStockTradeValue
Aug 17, 2026CLDI Calidi Biotherapeutics, IncBought (not open market)—
Jun 12, 2026KYNB Kyntra BIO, IncBought (not open market)—

Companies traded

  • CLDI Calidi Biotherapeutics, Inc: 1 buy, last Aug 17, 2026
  • KYNB Kyntra BIO, Inc: other filings, last Jun 12, 2026
  • FGEN Fibrogen Inc: 3 buys, 6 sales, last Jun 30, 2025
  • ANAB Anaptysbio Inc: other filings, last Feb 2, 2018
  • DEPO Depomed Inc: 5 buys, 3 sales, last Feb 8, 2017

Get free alerts when James A Schoeneck files a new trade →